FEDERATED HERMES, INC. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$3,000
+50.0%
196
+86.7%
0.00%
Q3 2018$2,000
-50.0%
105
-73.8%
0.00%
Q4 2016$4,000
-20.0%
400
-16.8%
0.00%
Q3 2016$5,0004810.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
VHCP Management II, LLC 315,980$3,381,0001.62%
VHCP Management, LLC 135,420$1,449,0001.56%
Eventide Asset Management 851,400$9,110,0000.59%
CARL DOMINO INC 26,000$278,0000.30%
SABBY MANAGEMENT, LLC 357,806$3,829,0000.22%
Telemetry Investments, L.L.C. 25,016$268,0000.15%
J. Goldman & Co LP 199,886$2,139,0000.14%
BAILARD, INC. 123,785$1,324,0000.12%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 94,945$1,015,0000.07%
Candriam S.C.A. 244,000$2,611,0000.06%
View complete list of STEMLINE THERAPEUTICS INC shareholders